3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Uterine Cervical Neoplasms
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Interventions
pembrolizumab
37
Paclitaxel
18
Cisplatin
18
Carboplatin
14
Nivolumab
13
Hyperthermic Intraperitoneal Chemotherapy
13
Docetaxel
11
Cyclophosphamide
11
Oxaliplatin
9
Irinotecan
9
Fluorouracil
9
atezolizumab
8
Trastuzumab
8
Leucovorin
8
Bevacizumab
8
fludarabine
7
Magnetic Resonance Spectroscopy
7
Specimen Handling
6
Ipilimumab
6
Gemcitabine
6
Mitomycin
5
Cytoreduction Surgical Procedures
5
Capecitabine
5
durvalumab
4
cemiplimab
4
aldesleukin
4
Taxes
4
Psychiatric Rehabilitation
4
Platinum
4
Drug Therapy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Molecular Diagnostic Techniques
×
Gynecologic
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled